Health
0
Comments
FDA Approves Flibanserin 'Little Pink Pill' Amid Controversy
The FDA has given the green light to Addyi, also known as the 'little pink pill' or flibanserin, designed to boost women's sexual desire. The approval follows an intense lobbying campaign and comes with several prescribing restrictions. Although hailed as a breakthrough for treating Hypoactive Sexual Desire Disorder (HSDD), the drug's effectiveness and safety remain points of contention among experts.
About
Health
Latest Posts
Dimethyl Fumarate: A Game Changer in Treating Autoimmune Diseases
By Orion Kingsworth Apr 29, 2023
Experience the Magic of Kombucha Tea: Nature's Most Potent Dietary Supplement
By Orion Kingsworth Jun 12, 2023
Amlodipine and POTS Syndrome: Can This Medication Help with Symptoms?
By Orion Kingsworth Apr 28, 2023
